Overweight and Obesity not only a threat to a healthy life, but it also affects the person emotionally, as well. Therefore, there is a vast range of treatment options available presently to choose from. The best suitable option varies from individual to individual and depends upon the person’s current health status, economic status, and personal choice.
One of the primary goals of losing weight is to reach and stay at a healthy ideal BMI at which the person is fit and active. In order to lose weight, the available options are Dietary Modification, Behavior Modification, Exercise, Prescription weight-loss medication, and several kinds of surgeries. Medications are an essential part of the morbid obesity treatment process however certain weight-loss drugs can have serious side effects.
DelveInsight's "Obesity Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the disease, historical and forecasted epidemiology, the pipeline insight as well as the Obesity market size and shares analysis in the seven major markets (7MM).
The report also covers emerging drugs, current treatment practices, Obesity Market Shares of the individual therapies, a detailed current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.
The report analyses the Obesity Market trends and developments in the seven major markets (i.e. the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan.
Obesity Market Key Facts
- As per a survey from 2017-2018 by National Health and Nutrition Examination Survey (NHANES), the age-adjusted prevalence of obesity among U.S. adults was 42.4% in 2017–2018.
- According to Organization for Economic Co-operation and Development (2019), it is estimated that just under one in four adults in Germany are obese. As a result, Germans live on average 2.6 years less due to being overweight.
- As per the statistics on Obesity, Physical Activity, and Diet, by the National Health Service (NHS) England (2020), the majority of adults were overweight or obese. Overall, 67% of men and 60% of women were classified as overweight or obese.
- In Canada, the prevalence is estimated to be 23% in adults and 8% in children, with rates expected to rise in the coming years (Gorber et al. 2008).
Obesity Market Trends
The market size of obesity is anticipated to increase during the study period owing to the increasing obese/overweight population. Apart from this, an increase in awareness programs and the expected entry of pharmacological therapies for the management of obesity/overweight in the 7MM will also play a major role.
The Obesity market analysis section of the report helps to understand the current and forecasted Obesity Market Trends and Growth by evaluating the impact of current therapies on the market, unmet needs, drivers, and barriers.
The report gives complete detail of Obesity Market Size and Shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
The dynamics of the Obesity Market is anticipated to change as companies across the globe are thoroughly working toward the development of new drug therapy options for Weight Loss/Weight Management/Obesity.
Some of the key Companies in the Obesity Market include Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk, NeonMind Biosciences, NeonMind Biosciences, and other Obesity Therapies covered in the report include Tirzepatide, BI 456906, Danuglipron, Semaglutide, Psilocybin, and many more.
Obesity Epidemiology Forecast
Obesity Epidemiology Segmentation
- Total Prevalent Cases of Obesity/Overweight
- Total diagnosed prevalent cases of Obesity/Overweight
- Total diagnosed prevalent cases of Obesity/Overweight segmented by gender
- Total diagnosed prevalent cases of Obesity/Overweight segmented by age
- Total treated cases of Obesity/Overweight segmented by therapies
The epidemiology section covers detailed insights about the patient pool for every seven major countries. It helps to recognize the causes of current and forecasted Obesity Epidemiology Trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
For more details, visit: Obesity Market Trends